JITC

Antitumor effect of CAR-T cells targeting transmembrane tumor necrosis factor alpha combined with PD-1 mAb on breast cancers
Hongping Ba, Zigang Dai, Zunyue Zhang, Peng Zhang, Bingjiao Yin, Jing Wang, Zhuoya Li, Xiaoxi Zhou

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e003837; DOI: 10.1136/jitc-2021-003837
Treg-selective IL-2 starvation synergizes with CD40 activation to sustain durable responses in lymphoma models
Kristin Stirm, Peter Leary, Daria Wüst, Dominique Stark, Nicole Joller, Ufuk Karakus, Onur Boyman, Alexandar Tzankov, Anne Müller

Journal for ImmunoTherapy of Cancer Feb 2023, 11 (2) e006263; DOI: 10.1136/jitc-2022-006263
Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors
Jasmine I Caulfield, Lilach Aizenbud, Ana Luisa Perdigoto, Eric Meffre, Lucia Jilaveanu, Dominika A Michalek, Stephen S Rich, Yariv Aizenbud, Adebowale Adeniran, Kevan C Herold, Matthew R Austin, Harriet Kluger

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e006570; DOI: 10.1136/jitc-2022-006570
Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination
Lieke L van der Woude, Mark A J Gorris, Inge M N Wortel, Jeroen H A Creemers, Kiek Verrijp, Kim Monkhorst, Katrien Grünberg, Michel M van den Heuvel, Johannes Textor, Carl G Figdor, Berber Piet, Willemijn S M E Theelen, I Jolanda M de Vries

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e005248; DOI: 10.1136/jitc-2022-005248
First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors
Omid Hamid, Alberto A Chiappori, John A Thompson, Toshihiko Doi, Siwen Hu-Lieskovan, Ferry A L M Eskens, Willeke Ros, Adi Diab, Jean-Philippe Spano, Naiyer A Rizvi, Jeffrey S Wasser, Eric Angevin, Patrick A Ott, Alison Forgie, Wenjing Yang, Cen Guo, Jeffrey Chou, Anthony B El-Khoueiry

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e005471; DOI: 10.1136/jitc-2022-005471
Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer
Adrienne G Waks, Tanya E Keenan, Tianyu Li, Nabihah Tayob, Gerburg M Wulf, Edward T Richardson, Victoria Attaya, Leilani Anderson, Elizabeth A Mittendorf, Beth Overmoyer, Eric P Winer, Ian E Krop, Judith Agudo, Eliezer M Van Allen, Sara M Tolaney

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e005119; DOI: 10.1136/jitc-2022-005119
H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2⁺ patients with diffuse midline glioma
Lena Immisch, George Papafotiou, Oliver Popp, Philipp Mertins, Thomas Blankenstein, Gerald Willimsky

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e005535; DOI: 10.1136/jitc-2022-005535
Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization
Qi Zhang, Bingqiu Xiu, Liyi Zhang, Ming Chen, Weiru Chi, Lun Li, Rong Guo, Jingyan Xue, Benlong Yang, Xiaoyan Huang, Zhi-Ming Shao, Shenglin Huang, Yayun Chi, Jiong Wu

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e004666; DOI: 10.1136/jitc-2022-004666
Autophagic flux restoration enhances the antitumor efficacy of tumor infiltrating lymphocytes
Chaoting Zhang, Yizhe Sun, Shance Li, Luyan Shen, Xia Teng, Yefei Xiao, Nan Wu, Zheming Lu

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e004868; DOI: 10.1136/jitc-2022-004868
PD-L1/TLR7 dual-targeting nanobody-drug conjugate mediates potent tumor regression via elevating tumor immunogenicity in a host-expressed PD-L1 bias-dependent way
Xiaolu Yu, Yiru Long, Binfan Chen, Yongliang Tong, Mengwen Shan, Xiaomin Jia, Chao Hu, Meng Liu, Ji Zhou, Feng Tang, Henglei Lu, Runqiu Chen, Pan Xu, Wei Huang, Jin Ren, Yakun Wan, Jianhua Sun, Jia Li, Guangyi Jin, Likun Gong

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e004590; DOI: 10.1136/jitc-2022-004590

Main menu

JITC

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

JITC

Pages